Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Atossa Genetics Inc
YAG2Current price
1.31 EUR
-0.042 EUR (-3.11%)
Last closed
1.37 USD
Company
www.atossatherapeutics.com
ISIN
US04962H5063
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
203 726 336 USD
Yield for 12 month
+109.38 %
1Y
3Y
5Y
10Y
15Y
YAG2
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company's lead drug candidate is oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develops immunotherapy/chimeric antigen receptor therapy programs. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington. Address: 107 Spring Street, Seattle, WA, United States, 98104
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
5.5 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
+18 000 USD
Current Year
-23 000 USD
Last Year
-8 000 USD
Current Quarter
-4 000 USD
Last Quarter
-5 000 USD
Key Figures YAG2
1 year
3 years
5 years
10 years
EBITDA
-30 546 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-19.68 %
PEG Ratio
–
Return On Equity TTM
-28 %
Wall Street Target Price
5.5 USD
Revenue TTM
–
Book Value
0.64 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.21 USD
Diluted Eps TTM
-0.21 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics YAG2
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History YAG2
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:12
Payout Ratio
–
Last Split Date
20.04.2018
Dividend Date
20.04.2018
Stock Valuation YAG2
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
2.0051
Price Book MRQ
2.3532
Financials YAG2
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators YAG2
For 52 weeks
0.63 USD
2.31 USD
50 Day MA
1.44 USD
Shares Short Prior Month
12 928 634
200 Day MA
1.36 USD
Short Ratio
24.78
Shares Short
13 051 696
Short Percent
10.38 %
BeatStart